Welcome to LookChem.com Sign In|Join Free
  • or
3-Oxazolidinecarboxylic acid, 4-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-5-oxo-, phenylmethyl ester, (4R)- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

918409-08-2

Post Buying Request

918409-08-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

918409-08-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 918409-08-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,8,4,0 and 9 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 918409-08:
(8*9)+(7*1)+(6*8)+(5*4)+(4*0)+(3*9)+(2*0)+(1*8)=182
182 % 10 = 2
So 918409-08-2 is a valid CAS Registry Number.

918409-08-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name (4R)-4-(tert-butyl-dimethyl-silanyloxymethyl)-5-oxo-oxazolidine-3-carboxylic acid benzyl ester

1.2 Other means of identification

Product number -
Other names (R)-4-(tert-Butyl-dimethyl-silanyloxymethyl)-5-oxo-oxazolidine-3-carboxylic acid benzyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:918409-08-2 SDS

918409-08-2Relevant academic research and scientific papers

EP300/CREBBP INHIBITOR

-

, (2020/05/30)

The present invention provides a compound having excellent histone acetyltransferase inhibitory activity against EP300 and/or CREBBP, or a pharmacologically acceptable salt thereof. The compound is represented by the following formula (1) or a pharmacologically acceptable salt thereof: wherein ring Q1, ring Q2, R1, R2, R3 and R4 respectively have the same meanings as defined in the specification.

(2R)- and (2S)-3-fluoroalanine and their N-methyl derivatives: Synthesis and incorporation in peptide scaffolds

Hoveyda, Hamid R.,Pinault, Jean-Francois

, p. 5849 - 5852 (2007/10/03)

(Diagram presented) A convergent synthetic methodology has been developed to access both (2S)- and (2R)-3-fluoroalanine and their corresponding N-methyl analogues, in optically pure form, through a common oxazolidinone intermediate that can be obtained fr

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 918409-08-2